Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

RW Endocrinology > Type 2 Diabetes > Flashcards

Type 2 Diabetes Flashcards

1
Q

What is Type 2 diabetes characterised as?

A

Tissue insensitivity to insulin action (insulin resistance) and inability of pancreas to adapt so overproduction of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the core 2 physiological changes in type 2 diabetes?

A

Insulin resistance and B-cell dysfunction (genetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What actually is insulin resistance?

A

Down stream pathway – the receptor is not as responsive to the insulin molecule and therefore less glucose enters the cell. This results in a build up of glucose in the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes insulin resistance?

A
  • Ectopic Fat Accumulation and increase FFA circulation
  • Increase Inflammatory mediators (CRP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the classic clinical presentation for T2DM?

A
  • Middle-aged/eldery
  • obese
  • often CVD/pre-diabetic symptoms beforehand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What signs may there be on examination of T2DM?

A

Acanthosis Nigrocans (hyper pigmentation of the skin) Signs of other endocrine diseases eg. Cushings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the timeline of T2DM?

A
  1. Insulin resistance occurs and initially the beta -cells compensate by producing more insulin
  2. However eventually the resistance overcomes the production and hyperglycaemia and elevated FFAs causes beta-cell function declines, due to the glucotoxicity and lipotoxicity
  3. Then blood glucose levels increase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True/False: Diabetes can be reversed by diet change

A

True, by reducing fat levels in the pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What conditions are associated with T2DM in terms of PMH?

A
  • Gestational diabetes
  • Polycystic Ovarian Syndrome
  • Pancreatitis
  • Cystic fibrosis/Myotonic dystrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the general action of Biguanides, and which is the main example?

A

Insulin sensitisers and also reduces hepatic gluoconeogenesis - Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or False: Biguanides should not be given at a larger dose than 1g

A

True, there is little evidence of benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which T2DM medications are at risk of causing hypos?

A

Sulphonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which T2DM medications are weight neutral?

A

Metformin (Biguanides), DPP-IV inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the main side effects of metformin (Biguanides)?

A

Lactic acidosis, GI effects (nausea, DandV), liver failure and rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the first line treatment for T2DM?

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the general action and example of Sulphonylureas (SU)?

A

Insulin secretagogues - Glibencalmide, Gliceride, glipizide and glimepiride

17
Q

What is the mechanism of action of sulphonylureas?

A

SU bind to the sulphonylurea receptor subunits of KATP channels in the pancreatic β-cells, causing them to open independent of plasma glucose concentration to promote insulin secretion

18
Q

Which T2DM medications can cause weight gain?

A

Sulphonylureas and Thiazolidinediones

19
Q

Which T2DM medications shouldn’t be used in patients with renal or hepatic failure?

A

Sulphonylureas but also Metformin (biguanides)

20
Q

What is the general action and example of Thiazolidinediones (TZDs)/glitazones?

A

PPARγ agonists decreasing insulin resistance at target tissues - Pioglitazone

21
Q

In what age group are Thiazolidinediones (glitazones) not recommended?

A

>65y, due to the risk of hip fracture and heart failure

22
Q

What are the main side effects of Thiazolidinediones (glitazones?

A

Heart failure (due to fluid retention)

23
Q

What is the incretin effect?

A

Glucose which enters the body orally and is digested will produce a higher insulin response (more insulin) than if it was given IV. This is because when the oral glucose reaches the stomach and duodenum, it stimulates the release of digestive hormones (gastrin, GIP, CCK, Secretin) which can further enhance insulin secretion.

24
Q

What are examples of incretins?

A

GIP from K cells and GLP-1 from L cells (Hormones from intestines which stimulate insulin secretion in response to glucose)

25
Q

What is the general action and example of GLP-1 Receptor Agonists/Incretin analogues?

A

Promote insulin secretion by simulating incretins (but are longer lasting) - Liraglutide, Exanatide and Lixisenatide

26
Q

What is the general action and example of DPP-IV Inhibitors?

A

Inhibit the enzyme which breaks down incretins (DPP-4) - Vildagliptin, Sitagliptin, Saxagliptin, Linagliptin

27
Q

What is the general action and example of SGLT2 Inhibitors?

A

Block glucose reabsorption and promote excretion - Dapagliflozin, Canagliflozin and Empagliflozin

28
Q

Which T2DM medications can cause weight loss?

A

GLP-1 Receptor Agonists and sometimes Biguanides (Metformin)

29
Q

What are the main side effects of SGLT2 inhibitors?

A

Increase in thrush and UTIs

30
Q

Which form of insulin regime is mostly used in T2DM?

A

Basal insulin (less use of basal-bolus)

31
Q

What T2DM medications are insulin dependent?

A
  • Those increasing secretion of insulin: (e.g. sulfonylureas, incretin mimetics, glinides, DPP-4 inhibitors (gliptins)
  • Those decreasing insulin resistance e.g. biguanides, thiazolidinediones (glitazones)]
32
Q

Which T2DM medications are insulin independent?

A
  • α-glucosidase inhibitors
  • Sodium glucose type-2 (SGLT2) inhibitors]
33
Q

What is the general action and example of Glinides (Meglitinides)?

A

Insulin secretagogues - repaglinide and nateglinide

34
Q

What is the mechanism of action for Glinides (Meglitinides)/

A

Act similarly to the sulfonylureas – bind to SUR1 (at a distinct benzamido site) to close the KATP channel and trigger insulin release

35
Q

What is the general action and example of a-Glucosidase Inhibitors?

A

Inhibitors of a-glucosidase (duh) which normally breaks down starch and disaccharides to absorbable glucose - Acarbose

36
Q

What is the mechanism of action of Thiazolidinediones (TZDs, Glitazones)?

A
  • Act as exogenous agonists of the nuclear receptor PPARg) which associates with retinoid receptor X (RXR) - PPARg is largely confined to adipocytes.
  • Activated PPARg-RXR complex acts as a transcription factor that binds to DNA to promote the expression of genes encoding several proteins involved in insulin signalling, among other - Promote fatty acid uptake and storage in adipocytes, rather than skeletal muscle and liver

RW Endocrinology (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions